Wilson Sonsini Goodrich & Rosati advised General Atlantic on patent matters related to the transaction. Seaport Therapeutics (Seaport), a clinical-stage biopharmaceutical company that is advancing novel...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Goldman Sachs Alternatives on patent matters related to the transaction. Triveni Bio, a biotech company, announced the completion of a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Terray on the transaction. Terray Therapeutics (Terray), a biotechnology company, announced raising $120 million in Series B funding round. The...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Kairos Power in the transaction. Kairos Power and Google announced they have signed a Master Plant Development Agreement, creating a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Clearway Energy Group on the transaction. Clearway Energy Group (Clearway) announced that it has closed financing and begun construction on...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Movet on the transaction. Colombia-based Movet, a veterinary network, announced that it completed a $5 million Series A financing round...
You must be a Standard 1 Year member to access this content.
Morrison & Foerster advised Crinetics Pharmaceuticals, Inc. on the offering, Wilson Sonsini Goodrich & Rosati advised Crinetics on patent matters and Cooley advised the underwriters. Crinetics...
You must be a Standard 1 Year member to access this content.
Baker McKenzie represented H.Lundbeck A/S (Lundbeck) in the transaction, Cooley represented Longboard Pharmaceuticals and Wilson Sonsini Goodrich & Rosati represented Evercore, Longboard’s financial advisor. H. Lundbeck...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Cytovale on intellectual property strategy generally and advised the company on IP matters related to the transaction. Cytovale, a commercial-stage...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised MARAbio Systems, Inc. on intellectual property matters related to the transaction. MARAbio Systems, Inc. (MARAbio), a precision immunology company whose...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Relyance in the transaction. Relyance AI, a leading AI-powered data governance platform that provides complete visibility and control over enterprise-wide...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Verona Pharma on patent matters on the deal. Verona Pharma plc (Nasdaq: VRNA) announced that the U.S. Food and Drug...
You must be a Standard 1 Year member to access this content.
